Baricitinib
It is an FDA approved selective Janus Kinase 1 and 2 (JAK1 and JAK2) inhibitor used for the treatment of rheumatoid arthritis. It has a role as an antirheumatic drug, an EC 2.7.10.2 (non-specific protein-tyrosine kinase) inhibitor, an anti-inflammatory agent, an immunosuppressive agent and an antiviral agent.
| Catalog Number | API1187594097 |
| Alternative Name(s) | olumiant LY3009104 INCB028050 |
| Research Area | Other APIs |
| Molecular Formula | C16H17N7O2S |
| CAS# | 1187594-09-7 |
| SMILES | CCS(=O)(=O)N1CC(C1)(CC#N)N2C=C(C=N2)C3=C4C=CNC4=NC=N3 |
| Size | inquiry |
| Supplier Page | https://www.protheragen-ing.com/baricitinib-item-6341.html |